Beranda532488 • BOM
add
Divi's Laboratories Ltd
Tutup sebelumnya
₹3.964,05
Rentang hari
₹3.900,00 - ₹3.982,00
Rentang tahun
₹3.050,15 - ₹4.104,00
Kapitalisasi pasar
1,05Â T INR
Volume Rata-Rata
15,97Â rb
Rasio P/E
75,56
Hasil dividen
0,76%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 18,55Â M | 8,63% |
Biaya operasional | 7,32Â M | 13,20% |
Laba bersih | 3,58Â M | 16,69% |
Margin laba bersih | 19,30 | 7,40% |
Penghasilan per saham | 13,50 | 16,78% |
EBITDA | 4,79Â M | 20,13% |
Tarif pajak efektif | 26,79% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 36,11Â M | 8,22% |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 126,77 M | — |
Saham yang beredar | 265,19 jt | — |
Harga terhadap reservasi | 8,30 | — |
Tingkat pengembalian aset | — | — |
Pengembalian modal | 7,77% | — |
Arus Kas
Perubahan bersih tunai
| (INR) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 3,58Â M | 16,69% |
Kas dari operasi | — | — |
Tunai dari investasi | — | — |
Tunai dari pembiayaan | — | — |
Perubahan bersih tunai | — | — |
Arus kas bebas | — | — |
Tentang
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
Didirikan
12 Okt 1990
Situs
Karyawan
8.433
